Literature DB >> 1080679

The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects.

A Girolami, L De Marco, L Virgolini, R Peruffo, F Fabris.   

Abstract

Platelet aggregation by various inductors was studied in citrated and heparinized plasma of the following groups of subjects: Normal, hemophilia A, combined factor V and factor VIII deficiency, v. Willeprand's disease and congenital afibrinognemia. The results may be summarized as follows: A-platelet aggregation in citrated plasm 1) platelet aggregation by common inductors ADP, adrenalin and collagen was normal in all groups of subjects but for the patients with congential afibrinogenemia in whom adrenalin induced aggregation was absent or markedly refuced whereas ADP and collagen gave slightly reduced or near normal aggregation curves. 2) platelet aggregation by ristocetin was normal in all groups of subjects but for v. Willebrand's disease in which it was absent. B-platelet aggregation in heparized plasma. 1) platelet aggregation by common inductors resulted to be normal in all groups of subjects except in congenital afibrinogenemia. In this latter case the pattern was still mildly defective but here was an increased aggregation as compared to citrated plasma. These findings have been interpretemmon inductors. 2) platelet aggregation by ristocetin resulted to be absent in all groups of subjects investigated. The possible mechanism of action of the inhibitory effect exercised py heparin with regard to restocetin is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080679     DOI: 10.1007/bf01633505

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  26 in total

1.  MEASUREMENT OF PLATELET ADHESIVENESS. A SIMPLE IN VITRO TECHNIQUE DEMONSTRATING AN ABNORMALITY IN VON WILLEBRAND'S DISEASE.

Authors:  E W SALZMAN
Journal:  J Lab Clin Med       Date:  1963-11

2.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

3.  Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity.

Authors:  D Meyer; C S Jenkins; M D Dreyfus; E Fressinaud; M J Larrieu
Journal:  Br J Haematol       Date:  1974-12       Impact factor: 6.998

4.  Platelet refractory state induced by heparin.

Authors:  C Eika
Journal:  Scand J Haematol       Date:  1972

5.  Ultrastructure of ristocetin aggregated normal human platelets: tortuous boundaries and swollen granules.

Authors:  C H Ts'ao; D Green; E C Rossi
Journal:  Scand J Haematol       Date:  1973

6.  The platelet aggregating effect of eight commercial heparins.

Authors:  C Eika
Journal:  Scand J Haematol       Date:  1972

7.  Ristocetin--a new tool in the investigation of platelet aggregation.

Authors:  M A Howard; B G Firkin
Journal:  Thromb Diath Haemorrh       Date:  1971-10-31

8.  [Analysis of the platelet functions. Adhesion and aggregation of platelets with purified collagen].

Authors:  J P Caen; Y Legrand
Journal:  Rev Fr Etud Clin Biol       Date:  1968-12

9.  [Measurement of platelet aggregation. Anti-aggregating activity of heparin].

Authors:  J Aznar
Journal:  Hemostase       Date:  1966

10.  Platelet adhesiveness and aggregation in congenital afibrinogenemia. An investigation of three patients with post-transfusion, cross-correction studies between two of them.

Authors:  A Girolami; L De Marco; L Virgolini; R Peruffo; F Fabris
Journal:  Blut       Date:  1975-02
View more
  1 in total

1.  Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.

Authors:  M Sobel; P M McNeill; P L Carlson; J C Kermode; B Adelman; R Conroy; D Marques
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.